Search
for
Sort by
Research 271–300 of 864
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Identification and single-cell analysis of prognostic genes related to mitochondrial and neutrophil extracellular traps in bladder cancer
- The postnatal offspring of finasteride-treated male rats show altered ERα and PCNA expression in the liver
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Advances in the mechanism and new therapies of alopecia areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Iron Screening in Alopecia Areata Patients May Catch Hereditary Hemochromatosis Early
- CXCL12 inhibits hair growth through CXCR4
- In vitro study of methanolic extract of Eclipta alba Hassk. FOR hepg2 cell line
- Protein Kinase C as a Therapeutic Target
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Matriptase-2, A Novel Suppressor of Hepcidin.
- Skin epidermal keratinocyte p53 induces food uptake upon UV exposure
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Flavonoids and saponins: What have we got or missed?
- Pharmaceutical nanotechnology in Egypt: diverse applications and promising outcomes
- Therapies and nanotherapies for cervical cancer (Review)
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Systematic review on Abrus precatorius Linn. since 1871: ethnobotanical uses, phytochemistry and pharmacological properties
- Anticancer Effects of Broccoli Sprout Extract and Sulforaphane Through ROS-Induced MAPK Pathway in Breast Cancer Cells and Xenografts
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies